These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 1611632

  • 1. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ, van Hoogenhuyze DC, Kruijssen HA, Pieper PG, Bruggeling WA.
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.
    Anderson JL, Baim DS, Fein SA, Goldstein RA, LeJemtel TH, Likoff MJ.
    J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W.
    N Engl J Med; 1983 Sep 29; 309(13):748-56. PubMed ID: 6888453
    [Abstract] [Full Text] [Related]

  • 4. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb 29; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 5. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar 29; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 6. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA, Ward A.
    Drugs; 1988 Aug 29; 36(2):158-92. PubMed ID: 3053125
    [Abstract] [Full Text] [Related]

  • 7. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.
    Remme WJ, van der Ent M, Bartels GL, van Schelven D, van Hoogenhuyze DC, Krauss XH, Kruijssen HA, Storm CJ.
    Cardiovasc Drugs Ther; 1996 May 29; 10(2):137-44. PubMed ID: 8842505
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, Royal HD, Grossman W.
    Circulation; 1984 Dec 29; 70(6):1030-7. PubMed ID: 6499142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA, Chatterjee K, Cody RJ, Kubo SH, Leonard D, Daly P, Rutman H.
    J Am Coll Cardiol; 1985 Aug 29; 6(2):453-9. PubMed ID: 4019930
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
    Boesch C, Dubois-Rande JL, Pochmalicki G, Lellouche D, Teiger E, Saal JP, Cachin JC, Mallo C, Castaigne A, Jan F.
    Ann Cardiol Angeiol (Paris); 1992 Nov 29; 41(9):509-12. PubMed ID: 1298193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.